Presentation Preview: Beyond TopoI & Tubulin: Advancing a First-in-Class Protein Alkylation Payload ADC IKS073
- Positioning protein alkylation as a differentiated and emerging modality within the evolving ADC payload landscape
- Spotlighting the therapeutic potential of ProAlk™ payload through the preclinical profile of IKS073 targeting B7H3 in solid tumors
- Laying out future development journey to progress the first ProAlk™ payload ADC to the clinic